Review Article: Cerebrospinal fluid in human African trypanosomiasis: a key to diagnosis, therapeutic decision and post‐treatment follow‐up

Human African trypanosomiasis is a lethal parasitic infection with neurological involvement. Examination of the cerebrospinal fluid (CSF) plays an essential role in diagnosis, selection of treatment and post‐treatment follow‐up. This paper reviews clinical presentation, diagnosis and treatment of the disease, with emphasis on CSF characteristics and interpretation of the CSF results for therapeutic decision and post‐treatment follow‐up.

[1]  M. P. Hutchinson,et al.  Sleeping sickness in Europeans: a review of 109 cases. , 1966, The Journal of tropical medicine and hygiene.

[2]  V. Nantulya,et al.  Diagnosis of Trypanosoma brucei gambiense sleeping sickness using an antigen detection enzyme-linked immunosorbent assay. , 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[3]  P. Preux,et al.  Blood–cerebrospinal fluid barrier and intrathecal immunoglobulins compared to field diagnosis of central nervous system involvement in sleeping sickness , 2002, Journal of the Neurological Sciences.

[4]  V. Pentreath,et al.  Survival of Trypanosoma brucei brucei in cerebrospinal fluid. , 1992, Annals of tropical medicine and parasitology.

[5]  T. Baltz,et al.  The efficacy of pentamidine in the treatment of early-late stage Trypanosoma brucei gambiense trypanosomiasis. , 1996, The American journal of tropical medicine and hygiene.

[6]  L. Goodwin.  The pathology of African trypanosomiasis. , 1970, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[7]  C. Burri,et al.  Treatment of human African trypanosomiasis--present situation and needs for research and development. , 2002, The Lancet. Infectious diseases.

[8]  P. Mattern.  Etat acutel et résultats des techniques immunologiques utilisées à l'institut pasteur de Dakar pour le diagnostic et l'étude de la trypanosomiase humaine africanine. , 1968 .

[9]  V. Pentreath,et al.  The somnogenic T lymphocyte suppressor prostaglandin D2 is selectively elevated in cerebrospinal fluid of advanced sleeping sickness patients. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[10]  P. Simarro,et al.  Control of human African trypanosomiasis in the Quiçama focus, Angola. , 2002, Bulletin of the World Health Organization.

[11]  S. V. Nieuwenhove.  Present strategies in the treatment of human African trypanosomiasis , 1999 .

[12]  V. Jamonneau,et al.  IgM quantification in the cerebrospinal fluid of sleeping sickness patients by a latex card agglutination test , 2002, Tropical medicine & international health : TM & IH.

[13]  L. Rosengren,et al.  Detection of light subunit neurofilament and glial fibrillary acidic protein in cerebrospinal fluid of Trypanosoma brucei gambiense-infected patients. , 1999, The American journal of tropical medicine and hygiene.

[14]  F. Boa,et al.  [Human African trypanosomiasis in Ivory Coast: biological characteristics after treatment. 812 cases treated in the Daloa focus (Ivory Coast)]. , 2002, Bulletin de la Societe de pathologie exotique.

[15]  P. Büscher,et al.  A semi-quantitative ELISA for detection of Trypanosoma brucei gambiense specific antibodies in serum and cerebrospinal fluid of sleeping sickness patients. , 1998, Acta tropica.

[16]  J. Sternberg,et al.  Nitric oxide and cytokine synthesis in human African trypanosomiasis. , 2001, The Journal of infectious diseases.

[17]  P. Büscher,et al.  Improved latex agglutination test for detection of antibodies in serum and cerebrospinal fluid of Trypanosoma brucei gambiense infected patients. , 1999, Acta tropica.

[18]  M. Dumas,et al.  Clinical aspects of human African trypanosomiasis , 1999 .

[19]  V. Jamonneau,et al.  Stage determination and therapeutic decision in human African trypanosomiasis: value of polymerase chain reaction and immunoglobulin M quantification on the cerebrospinal fluid of sleeping sickness patients in Côte d'Ivoire , 2003, Tropical medicine & international health : TM & IH.

[20]  C. M. Bilenge,et al.  Sleeping sickness resurgence in the DRC: the past decade , 2001, Tropical medicine & international health : TM & IH.

[21]  V. Pentreath,et al.  Endotoxins in the blood and cerebrospinal fluid of patients with African sleeping sickness , 1996, Parasitology.

[22]  P. Büscher,et al.  Neuro-inflammatory risk factors for treatment failure in “early second stage” sleeping sickness patients treated with Pentamidine , 2003, Journal of Neuroimmunology.

[23]  J. Pépin,et al.  African trypanosomiasis and drug-induced encephalopathy: risk factors and pathogenesis. , 1991, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[24]  M. Dumas,et al.  [The detection of anti-galactocerebroside autoantibodies in human African trypanosomiasis]. , 1994, Bulletin de la Societe de pathologie exotique.

[25]  M. Dumas,et al.  Central nervous system involvement in African trypanosomiasis: presence of anti-galactocerebroside antibodies in patients' cerebrospinal fluid. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[26]  B. Greenwood,et al.  IgM and antibody measurement in the diagnosis and management of Gambian trypanosomiasis. , 1977, The American journal of tropical medicine and hygiene.

[27]  H. Tanowitz,et al.  African trypanosomiasis (sleeping sickness). , 2000 .

[28]  Patrick T.K. Woo.  Evaluation of the haematocrit centrifuge and other techniques for the field diagnosis of human trypanosomiasis and filariasis. , 1971, Acta tropica.

[29]  E. Bosmans,et al.  Interleukin (IL)-6, IL-8 and IL-10 in serum and CSF of Trypanosoma brucei gambiense sleeping sickness patients before and after treatment. , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[30]  T. Baltz,et al.  Assessment of central nervous system involvement in gambiense trypanosomiasis: value of the cerebro‐spinal white cell count , 1998, Tropical medicine & international health : TM & IH.

[31]  P. Kennedy.  Human African trypanosomiasis (sleeping sickness). , 1999, Releve epidemiologique hebdomadaire.

[32]  B. Greenwood,et al.  Cerebrospinal-fluid IgM in patients with sleeping-sickness. , 1973, Lancet.

[33]  B. Greenwood,et al.  Lymphocytic infiltration of the brain in sleeping sickness. , 1976, British medical journal.

[34]  H. Reiber,et al.  Intrathecal immune response pattern for improved diagnosis of central nervous system involvement in trypanosomiasis. , 2003, The Journal of infectious diseases.

[35]  M. Dumas,et al.  Detection and characterization of autoantibodies directed against neurofilament proteins in human African trypanosomiasis. , 1997, The American journal of tropical medicine and hygiene.

[36]  B. Greenwood,et al.  The pathogenesis of sleeping sickness. , 1980, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[37]  A. Stanghellini,et al.  The situation of sleeping sickness in Angola: a calamity , 2001, Tropical medicine & international health : TM & IH.

[38]  P. Cattand,et al.  Human African trypanosomiasis: use of double centrifugation of cerebrospinal fluid to detect trypanosomes. , 1988, Bulletin of the World Health Organization.

[39]  V. Pentreath,et al.  Endotoxin antibodies in African sleeping sickness , 1997, Parasitology.

[40]  Terry K. Smith,et al.  Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial , 2000, The Lancet.

[41]  N. Van Meirvenne,et al.  A card-agglutination test with stained trypanosomes (C.A.T.T.) for the serological diagnosis of T. B. gambiense trypanosomiasis. , 1978, Annales de la Societe belge de medecine tropicale.

[42]  J. Baker.  Control and surveillance of African trypanosomiasis. Report of a WHO Expert Committee. , 1999, World Health Organization technical report series.

[43]  E. Matovu,et al.  Detection of trypanosomes in suspected sleeping sickness patients in Uganda using the polymerase chain reaction. , 2000, Bulletin of the World Health Organization.

[44]  K. Howard.  HISTOLOGICAL OBSERVATIONS ON SLEEPING SICKNESS AND OTHER TRYPANOSOME INFECTIONS , 1908 .

[45]  P. Kennedy,et al.  Human African trypanosomiasis of the CNS: current issues and challenges. , 2004, The Journal of clinical investigation.

[46]  V. Jamonneau,et al.  Human African trypanosomiasis: quantitative and qualitative assessment of intrathecal immune response , 2003 .

[47]  D. Evans,et al.  Trypanosoma brucei: Miniature anion-exchange centrifugation technique for detection of low parasitaemias: Adaptation for field use. , 1979, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[48]  V. Jamonneau,et al.  Use of polymerase chain reaction in human African trypanosomiasis stage determination and follow-up. , 1999, Bulletin of the World Health Organization.

[49]  A. Moore,et al.  Re‐emergence of epidemic sleeping sickness in southern Sudan , 2001, Tropical medicine & international health : TM & IH.

[50]  P. Lambert,et al.  Immune complexes in serum and in cerebrospinal fluid in African trypanosomiasis. Correlation with polyclonal B cell activation and with intracerebral immunoglobulin synthesis. , 1981, The Journal of clinical investigation.

[51]  P. Büscher,et al.  Single centrifugation of cerebrospinal fluid in a sealed pasteur pipette for simple, rapid and sensitive detection of trypanosomes. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[52]  M. Dumas,et al.  Treatment of human African trypanosomiasis. , 1983, Bulletin of the World Health Organization.

[53]  C. L. Laveran,et al.  Trypanosomes et trypanosomiases / par A. Laveran et F. Mesnil. , 1912 .

[54]  T. Niyonsenga,et al.  Gambiense trypanosomiasis: frequency of, and risk factors for, failure of melarsoprol therapy. , 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[55]  P. Vounatsou,et al.  Efficacy of 10-day melarsoprol schedule 2 years after treatment for late-stage gambiense sleeping sickness , 2004, The Lancet.

[56]  Timothy Planche,et al.  A novel and accurate diagnostic test for human African trypanosomiasis , 2004, The Lancet.

[57]  N. Meirvenne.  Biological diagnosis of human African trypanosomiasis , 1999 .